Dianthus Therapeutics Inc. (DNTH) — Financial Flexibility Index
Dianthus Therapeutics Inc. (DNTH) has a Financial Flexibility Index of -1.25x as of December 2025. Free cash flow of $-46.84 Million (operating CF $-46.98 Million minus capex $138.00K) represents -1% of total liabilities ($37.52 Million). Also explore net asset momentum of Dianthus Therapeutics Inc. to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Dianthus Therapeutics Inc. Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Dianthus Therapeutics Inc. across 10 annual periods. Check Dianthus Therapeutics Inc. (DNTH) strategic asset index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Dianthus Therapeutics Inc. (2016–2025)
Year-by-year free cash flow to debt coverage for Dianthus Therapeutics Inc.. For the full company profile including market capitalisation, see Dianthus Therapeutics Inc. stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.43x | $-128.85 Million | $-129.06 Million | $37.52 Million | ▲ +5.3% |
| 2024 | -3.63x | $-78.08 Million | $-78.18 Million | $21.53 Million | ▼ -3.9% |
| 2023 | -3.49x | $-36.75 Million | $-36.86 Million | $10.54 Million | ▼ -14.0% |
| 2022 | -3.06x | $-28.93 Million | $-29.07 Million | $9.45 Million | ▲ +9.3% |
| 2021 | -3.38x | $-58.27 Million | $-59.53 Million | $17.26 Million | ▲ +6.0% |
| 2020 | -3.59x | $-63.62 Million | $-64.02 Million | $17.71 Million | ▼ -35.1% |
| 2019 | -2.66x | $-54.04 Million | $-57.10 Million | $20.32 Million | ▲ +9.3% |
| 2018 | -2.93x | $-34.21 Million | $-41.89 Million | $11.66 Million | ▲ +39.5% |
| 2017 | -4.84x | $-20.06 Million | $-22.26 Million | $4.14 Million | ▼ -74.4% |
| 2016 | -2.78x | $-6.39 Million | $-6.53 Million | $2.30 Million | — |